Ocugen Shares Rise 9% After OCU500 Inclusion in NIAID Trial
By Chris Wack Ocugen shares were up 9% at 45 cents after the company said the National Institute of Allergy and Infectious Diseases, a part of the National...
Source: marketwatch.com
Page 49 - Service Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Service Testing Today - Breaking & Trending Today
Cytokinetics Shares Rise 11% With Aficamten Heart Drug Trial Results Expected by Year End
By Ben Glickman Shares of Cytokinetics rose after the company said it expected topline results from its aficamten heart drug trial by the end of the year....
Source: marketwatch.com
Amgen to continue to seek full approval of Lumakras cancer drug after FDA panel votes against it
Amgen will continue to seek full approval for its Lumakras cancer drug as a treatment for a form of lung cancer.
Source: marketwatch.com
Tenaya Therapeutics Shares Up 16% After Patient Dosed With TN-201 Gene Heart Therapy
By Chris Wack Tenaya Therapeutics shares were up 16% to $2.55 one day after the company said the first patient has been dosed with TN-201 gene therapy for...
Source: marketwatch.com
Longeveron stock jumps on Alzheimer's trial results
Treatment derived from bone marrow shows promise in patients with mild Alzheimer's disease.
Source: marketwatch.com